← United States · Coverage record
US · SEC FORM 4
Disc Medicine, Inc.
IRON · Nasdaq · CIK 0001816736 · Healthcare · Biotechnology
INSIDER SIGNAL
0 qualifying P purchase groups
in the current 180-day scoring window
59 Form 4 transaction lines observed in the same window
39 sales · 20 option, withholding, award, gift or other lines
WHY NO ACTIVE SIGNAL?
Score anatomy
No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.
Why is there no score?
- No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
- Sales and other Form 4 activity remain visible as context and do not create a negative score.
Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.
Insider activity timeline
Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.
—
Purchase breadth, concentration & cluster buying
These modules activate when qualifying purchases enter the 180-day research window.
SIGNAL HISTORY
Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2024-06-17 · Bitterman Kevin.
Recent Form 4 activity
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
Market context
Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.
Short interest
Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.
- Shares short
- 7,270,420
- Previous report
- 7,207,702
- Avg daily volume
- 568,317
- Days to cover
- 12.8
FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.
Historical equity purchases
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2024-06-17 | ORBIMED ADVISORS LLC; OrbiMed Capital GP VI LLC; OrbiMed Capital GP VIII LLC; OrbiMed Genesis GP LLC | Purchase (P) | Common Stock | 83,334 | USD 36.00 | USD 3,000,024 | SEC filing ↗ |
| 2024-06-17 | Bitterman Kevin | Purchase (P) | Common Stock | 222,223 | USD 36.00 | USD 8,000,028 | SEC filing ↗ |
| 2024-06-17 | Ashiya Mona | Purchase (P) | Common Stock | 83,334 | USD 36.00 | USD 3,000,024 | SEC filing ↗ |
| 2023-02-15 | ORBIMED ADVISORS LLC; OrbiMed Capital GP VI LLC; OrbiMed Capital GP VIII LLC; OrbiMed Genesis GP LLC | Purchase (P) | Common Stock | 108,696 | USD 23.00 | USD 2,500,008 | SEC filing ↗ |
| 2023-02-15 | Ashiya Mona | Purchase (P) | Common Stock | 108,696 | USD 23.00 | USD 2,500,008 | SEC filing ↗ |
| 2023-02-15 | ACCESS INDUSTRIES MANAGEMENT, LLC; AI DMI LLC; Access Industries Holdings LLC; Blavatnik Len | Purchase (P) | Common Stock | 434,783 | USD 23.00 | USD 10,000,009 | SEC filing ↗ |
| 2022-04-13 | Leonard Braden Michael | Purchase (P) | Common Stock | 191,769 | USD 1.52 | USD 291,489 | SEC filing ↗ |
| 2022-04-12 | Leonard Braden Michael | Purchase (P) | Common Stock | 258,744 | USD 1.41 | USD 364,666 | SEC filing ↗ |
| 2022-04-11 | Leonard Braden Michael | Purchase (P) | Common Stock | 504,487 | USD 1.35 | USD 681,057 | SEC filing ↗ |
| 2021-05-14 | Piekos Brian | Purchase (P) | Common Stock | 7,655 | USD 9.46 | USD 72,416 | SEC filing ↗ |
| 2021-05-14 | Meyenburg Jason Patrick | Purchase (P) | Common Stock | 13,000 | USD 9.46 | USD 122,980 | SEC filing ↗ |
| 2020-08-14 | FS Development Holdings, LLC; Foresite Capital Fund V, L.P.; Foresite Capital Management V, LLC; Tananbaum James B. | Purchase (P) | Class A Common Stock | 441,500 | USD 10.00 | USD 4,415,000 | SEC filing ↗ |
Form 4 evidence
127 transaction lines in the latest 365-day window; 482 in local history.
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-09-15 | Quisel John D | Option exercise / conversion (M) | Common Stock | 36,000 | USD 1.01 | USD 36,360 | SEC filing ↗ |
| 2026-09-11 | Bitterman Kevin | Sale (S) | Common Stock | 27,136 | USD 70.11 | USD 1,902,505 | SEC filing ↗ |
| 2026-09-11 | Bitterman Kevin | Option exercise / conversion (M) | Common Stock | 27,136 | USD 45.07 | USD 1,223,144 | SEC filing ↗ |
Show recent Form 4 evidence (30 grouped rows)
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-09-15 | Quisel John D | Option exercise / conversion (M) | Common Stock | 36,000 | USD 1.01 | USD 36,360 | SEC filing ↗ |
| 2026-09-11 | Bitterman Kevin | Sale (S) | Common Stock | 27,136 | USD 70.11 | USD 1,902,505 | SEC filing ↗ |
| 2026-09-11 | Bitterman Kevin | Option exercise / conversion (M) | Common Stock | 27,136 | USD 45.07 | USD 1,223,144 | SEC filing ↗ |
| 2026-09-04 | Bitterman Kevin | Sale (S) | Common Stock | 1,689 | USD 79.96 | USD 135,052 | SEC filing ↗ |
| 2026-09-03 | Bitterman Kevin | Sale (S) | Common Stock | 5,203 | USD 79.98 | USD 416,136 | SEC filing ↗ |
| 2026-09-02 | Bitterman Kevin | Sale (S) | Common Stock | 49,164 | USD 80.17 | USD 3,941,495 | SEC filing ↗ |
| 2026-09-01 | Bitterman Kevin | Sale (S) | Common Stock | 129 | USD 79.95 | USD 10,314 | SEC filing ↗ |
| 2026-08-25 | Yu Jonathan Yen-Wen | Sale (S) | Common Stock | 8,796 | USD 83.12 | USD 731,124 | SEC filing ↗ |
| 2026-08-25 | Yu Jonathan Yen-Wen | Option exercise / conversion (M) | Common Stock | 8,796 | USD 13.50 | USD 118,746 | SEC filing ↗ |
| 2026-08-24 | Yu Jonathan Yen-Wen | Sale (S) | Common Stock | 300 | USD 82.53 | USD 24,759 | SEC filing ↗ |
| 2026-08-24 | Yu Jonathan Yen-Wen | Option exercise / conversion (M) | Common Stock | 300 | USD 13.50 | USD 4,050 | SEC filing ↗ |
| 2026-08-17 | Quisel John D | Sale (S) | Common Stock | 33,000 | USD 79.15 | USD 2,612,052 | SEC filing ↗ |
| 2026-08-17 | Quisel John D | Option exercise / conversion (M) | Common Stock | 33,000 | USD 13.50 | USD 445,500 | SEC filing ↗ |
| 2026-08-12 | Yu Jonathan Yen-Wen | Sale (S) | Common Stock | 804 | USD 82.64 | USD 66,443 | SEC filing ↗ |
| 2026-08-12 | Yu Jonathan Yen-Wen | Option exercise / conversion (M) | Common Stock | 804 | USD 13.50 | USD 10,854 | SEC filing ↗ |
| 2026-08-06 | Khara Rahul | Sale (S) | Common Stock | 5,000 | USD 80.00 | USD 400,000 | SEC filing ↗ |
| 2026-08-06 | Khara Rahul | Option exercise / conversion (M) | Common Stock | 5,000 | USD 14.69 | USD 73,450 | SEC filing ↗ |
| 2026-07-13 | Quisel John D | Sale (S) | Common Stock | 33,000 | USD 74.96 | USD 2,473,791 | SEC filing ↗ |
| 2026-07-13 | Quisel John D | Option exercise / conversion (M) | Common Stock | 33,000 | USD 10.68 | USD 352,374 | SEC filing ↗ |
| 2026-07-07 | Yu Jonathan Yen-Wen | Sale (S) | Common Stock | 100 | USD 82.50 | USD 8,250 | SEC filing ↗ |
| 2026-07-07 | Yu Jonathan Yen-Wen | Option exercise / conversion (M) | Common Stock | 100 | USD 13.50 | USD 1,350 | SEC filing ↗ |
| 2026-06-29 | Khara Rahul | Sale (S) | Common Stock | 1,649 | USD 75.00 | USD 123,675 | SEC filing ↗ |
| 2026-06-29 | Khara Rahul | Option exercise / conversion (M) | Common Stock | 1,649 | USD 14.69 | USD 24,224 | SEC filing ↗ |
| 2026-06-26 | Yu Jonathan Yen-Wen | Sale (S) | Common Stock | 300 | USD 72.50 | USD 21,750 | SEC filing ↗ |
| 2026-06-26 | Yu Jonathan Yen-Wen | Option exercise / conversion (M) | Common Stock | 300 | USD 13.50 | USD 4,050 | SEC filing ↗ |
| 2026-06-26 | Khara Rahul | Sale (S) | Common Stock | 851 | USD 75.00 | USD 63,825 | SEC filing ↗ |
| 2026-06-26 | Khara Rahul | Option exercise / conversion (M) | Common Stock | 851 | USD 14.69 | USD 12,501 | SEC filing ↗ |
| 2026-06-22 | Yu Jonathan Yen-Wen | Sale (S) | Common Stock | 9,700 | USD 72.66 | USD 704,802 | SEC filing ↗ |
| 2026-06-22 | Yu Jonathan Yen-Wen | Option exercise / conversion (M) | Common Stock | 9,700 | USD 13.50 | USD 130,950 | SEC filing ↗ |
| 2026-06-18 | Quisel John D | Sale (S) | Common Stock | 34,000 | USD 70.22 | USD 2,387,328 | SEC filing ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
Snapshot & identity
| Snapshot date | 2026-10-18 |
|---|---|
| Ranking version | US-v1.2 |
| Data quality | PASS ELIGIBLE · — |
| Ticker | IRON |
| CIK | 0001816736 |
| Sector | Healthcare |
| Industry | Biotechnology Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| Exchange | Nasdaq |
Data coverage
| Local Form 4 history | 482 transaction lines from 2020-08-14 to 2026-09-15 21 P purchase lines · 350 S sale lines · 111 other lines |
|---|---|
| SEC company submissions | Open SEC filings ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.